RAFFA WEALTH MANAGEMENT, LLC’s Sarepta Therapeutics SRPT Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8	Closed	-$174	–	1672
2026 Q1	$174	Hold	8	–	–	﹤0.01%	1201
2025 Q4	$172	Hold	8	–	–	﹤0.01%	1139
2025 Q3	$154	Hold	8	–	–	﹤0.01%	1155
2025 Q2	$137	Hold	8	–	–	﹤0.01%	1084
2025 Q1	$511	Hold	8	–	–	﹤0.01%	955
2024 Q4	$973	Hold	8	–	–	﹤0.01%	876
2024 Q3	$999	Sell	8 -49	-86%	-$6.77K	﹤0.01%	841
2024 Q2	$9.01K	Buy	57 +49	+613%	+$6.29K	﹤0.01%	458
2024 Q1	$1.04K	Hold	8	–	–	﹤0.01%	885
2023 Q4	$771	Hold	8	–	–	﹤0.01%	892
2023 Q3	$970	Hold	8	–	–	﹤0.01%	796
2023 Q2	$916	Hold	8	–	–	﹤0.01%	820
2023 Q1	$1.1K	Hold	8	–	–	﹤0.01%	757
2022 Q4	$1.04K	Hold	8	–	–	﹤0.01%	772
2022 Q3	$884	Hold	8	–	–	﹤0.01%	842
2022 Q2	$600	Hold	8	–	–	﹤0.01%	973
2022 Q1	$625	Hold	8	–	–	﹤0.01%	1012
2021 Q4	$720	Hold	8	–	–	﹤0.01%	981
2021 Q3	$740	Hold	8	–	–	﹤0.01%	948
2021 Q2	$622	Hold	8	–	–	﹤0.01%	1005
2021 Q1	$596	Hold	8	–	–	﹤0.01%	1013
2020 Q4	$1.36K	Hold	8	–	–	﹤0.01%	663
2020 Q3	$1.12K	Hold	8	–	–	﹤0.01%	637
2020 Q2	$1.28K	Hold	8	–	–	﹤0.01%	588
2020 Q1	$783	Hold	8	–	–	﹤0.01%	653
2019 Q4	$1.03K	Hold	8	–	–	﹤0.01%	618
2019 Q3	$603	Buy	+8	New	+$945	﹤0.01%	701
2019 Q2	–	Sell	-8	Closed	-$954	–	1296
2019 Q1	$954	Hold	8	–	–	﹤0.01%	586
2018 Q4	$873	Sell	8 -4	-33%	-$500	﹤0.01%	594
2018 Q3	$1.94K	Hold	12	–	–	﹤0.01%	399
2018 Q2	$1.59K	Buy	+12	New	+$1.13K	﹤0.01%	420
2017 Q3	–	Sell	-12	Closed	-$405	–	378
2017 Q2	$405	Hold	12	–	–	﹤0.01%	393
2017 Q1	$355	Hold	12	–	–	﹤0.01%	369
2016 Q4	$329	Hold	12	–	–	﹤0.01%	852
2016 Q3	$737	Buy	+12	New	+$363	﹤0.01%	530

Other funds holding SRPT

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's SRPT Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 8 shares — an estimated $174 sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in SRPT in Q3 2016 and held it in 35 quarters. The position peaked at $9.01K in Q2 2024. 57 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
RAFFA WEALTH MANAGEMENT, LLC sold 8 Sarepta Therapeutics shares in Q2 2026, an estimated $174.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Sarepta Therapeutics in Q3 2016 and held it in 35 quarters.
RAFFA WEALTH MANAGEMENT, LLC's Sarepta Therapeutics position peaked at $9.01K in Q2 2024.
57 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.